BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 19270706)

  • 1. Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma.
    Northcott PA; Nakahara Y; Wu X; Feuk L; Ellison DW; Croul S; Mack S; Kongkham PN; Peacock J; Dubuc A; Ra YS; Zilberberg K; McLeod J; Scherer SW; Sunil Rao J; Eberhart CG; Grajkowska W; Gillespie Y; Lach B; Grundy R; Pollack IF; Hamilton RL; Van Meter T; Carlotti CG; Boop F; Bigner D; Gilbertson RJ; Rutka JT; Taylor MD
    Nat Genet; 2009 Apr; 41(4):465-72. PubMed ID: 19270706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant patterns of H3K4 and H3K27 histone lysine methylation occur across subgroups in medulloblastoma.
    Dubuc AM; Remke M; Korshunov A; Northcott PA; Zhan SH; Mendez-Lago M; Kool M; Jones DT; Unterberger A; Morrissy AS; Shih D; Peacock J; Ramaswamy V; Rolider A; Wang X; Witt H; Hielscher T; Hawkins C; Vibhakar R; Croul S; Rutka JT; Weiss WA; Jones SJ; Eberhart CG; Marra MA; Pfister SM; Taylor MD
    Acta Neuropathol; 2013 Mar; 125(3):373-84. PubMed ID: 23184418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MLL4 Is Required to Maintain Broad H3K4me3 Peaks and Super-Enhancers at Tumor Suppressor Genes.
    Dhar SS; Zhao D; Lin T; Gu B; Pal K; Wu SJ; Alam H; Lv J; Yun K; Gopalakrishnan V; Flores ER; Northcott PA; Rajaram V; Li W; Shilatifard A; Sillitoe RV; Chen K; Lee MG
    Mol Cell; 2018 Jun; 70(5):825-841.e6. PubMed ID: 29861161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The genetic landscape of the childhood cancer medulloblastoma.
    Parsons DW; Li M; Zhang X; Jones S; Leary RJ; Lin JC; Boca SM; Carter H; Samayoa J; Bettegowda C; Gallia GL; Jallo GI; Binder ZA; Nikolsky Y; Hartigan J; Smith DR; Gerhard DS; Fults DW; VandenBerg S; Berger MS; Marie SK; Shinjo SM; Clara C; Phillips PC; Minturn JE; Biegel JA; Judkins AR; Resnick AC; Storm PB; Curran T; He Y; Rasheed BA; Friedman HS; Keir ST; McLendon R; Northcott PA; Taylor MD; Burger PC; Riggins GJ; Karchin R; Parmigiani G; Bigner DD; Yan H; Papadopoulos N; Vogelstein B; Kinzler KW; Velculescu VE
    Science; 2011 Jan; 331(6016):435-9. PubMed ID: 21163964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations.
    Pugh TJ; Weeraratne SD; Archer TC; Pomeranz Krummel DA; Auclair D; Bochicchio J; Carneiro MO; Carter SL; Cibulskis K; Erlich RL; Greulich H; Lawrence MS; Lennon NJ; McKenna A; Meldrim J; Ramos AH; Ross MG; Russ C; Shefler E; Sivachenko A; Sogoloff B; Stojanov P; Tamayo P; Mesirov JP; Amani V; Teider N; Sengupta S; Francois JP; Northcott PA; Taylor MD; Yu F; Crabtree GR; Kautzman AG; Gabriel SB; Getz G; Jäger N; Jones DT; Lichter P; Pfister SM; Roberts TM; Meyerson M; Pomeroy SL; Cho YJ
    Nature; 2012 Aug; 488(7409):106-10. PubMed ID: 22820256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of
    Dobson THW; Hatcher RJ; Swaminathan J; Das CM; Shaik S; Tao RH; Milite C; Castellano S; Taylor PH; Sbardella G; Gopalakrishnan V
    Mol Cancer Res; 2017 Aug; 15(8):1073-1084. PubMed ID: 28483947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of tumour-specific epigenetic events in medulloblastoma development by hypermethylation profiling.
    Lindsey JC; Lusher ME; Anderton JA; Bailey S; Gilbertson RJ; Pearson AD; Ellison DW; Clifford SC
    Carcinogenesis; 2004 May; 25(5):661-8. PubMed ID: 14688019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a novel homozygous deletion region at 6q23.1 in medulloblastomas using high-resolution array comparative genomic hybridization analysis.
    Hui AB; Takano H; Lo KW; Kuo WL; Lam CN; Tong CY; Chang Q; Gray JW; Ng HK
    Clin Cancer Res; 2005 Jul; 11(13):4707-16. PubMed ID: 16000565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and epigenetic inactivation of Kruppel-like factor 4 in medulloblastoma.
    Nakahara Y; Northcott PA; Li M; Kongkham PN; Smith C; Yan H; Croul S; Ra YS; Eberhart C; Huang A; Bigner D; Grajkowska W; Van Meter T; Rutka JT; Taylor MD
    Neoplasia; 2010 Jan; 12(1):20-7. PubMed ID: 20072650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete loss of H3K9 methylation dissolves mouse heterochromatin organization.
    Montavon T; Shukeir N; Erikson G; Engist B; Onishi-Seebacher M; Ryan D; Musa Y; Mittler G; Meyer AG; Genoud C; Jenuwein T
    Nat Commun; 2021 Jul; 12(1):4359. PubMed ID: 34272378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation-specific multiplex ligation-dependent probe amplification and its impact on clinical findings in medulloblastoma.
    Feierabend D; Walter J; Grube S; Herbold C; Beetz C; Kalff R; Ewald C
    J Neurooncol; 2014 Jan; 116(2):213-20. PubMed ID: 24162828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined genome-wide allelotyping and copy number analysis identify frequent genetic losses without copy number reduction in medulloblastoma.
    Langdon JA; Lamont JM; Scott DK; Dyer S; Prebble E; Bown N; Grundy RG; Ellison DW; Clifford SC
    Genes Chromosomes Cancer; 2006 Jan; 45(1):47-60. PubMed ID: 16149064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel amplifications in pediatric medulloblastoma identified by genome-wide copy number profiling.
    Nord H; Pfeifer S; Nilsson P; Sandgren J; Popova S; Strömberg B; Alafuzoff I; Nistér M; Díaz de Ståhl T
    J Neurooncol; 2012 Mar; 107(1):37-49. PubMed ID: 21979893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone H3 lysine 4 methyltransferase is required for facultative heterochromatin at specific loci.
    Zhu Q; Ramakrishnan M; Park J; Belden WJ
    BMC Genomics; 2019 May; 20(1):350. PubMed ID: 31068130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of oncogene amplifications in medulloblastomas by comparative genomic hybridization and array-based comparative genomic hybridization.
    Tong CY; Hui AB; Yin XL; Pang JC; Zhu XL; Poon WS; Ng HK
    J Neurosurg; 2004 Feb; 100(2 Suppl Pediatrics):187-93. PubMed ID: 14758948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Redefining the molecular substructure of medulloblastoma.
    Benmaamar R
    Lancet Oncol; 2017 Sep; 18(9):e514. PubMed ID: 28757377
    [No Abstract]   [Full Text] [Related]  

  • 17. Writing, erasing and reading histone lysine methylations.
    Hyun K; Jeon J; Park K; Kim J
    Exp Mol Med; 2017 Apr; 49(4):e324. PubMed ID: 28450737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The roles of histone lysine methylation in epigenetic regulation].
    Du TT; Huang QH
    Yi Chuan; 2007 Apr; 29(4):387-92. PubMed ID: 17548299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PCDH10 is a candidate tumour suppressor gene in medulloblastoma.
    Bertrand KC; Mack SC; Northcott PA; Garzia L; Dubuc A; Pfister SM; Rutka JT; Weiss WA; Taylor MD
    Childs Nerv Syst; 2011 Aug; 27(8):1243-9. PubMed ID: 21597995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depletion of G9a gene induces cell apoptosis in human gastric carcinoma.
    Lin X; Huang Y; Zou Y; Chen X; Ma X
    Oncol Rep; 2016 May; 35(5):3041-9. PubMed ID: 27081761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.